<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 27-year old woman is presented with a five year old history of <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> in whom recently peripheral <z:mp ids='MP_0008852'>retinal neovascularization</z:mp> in both eyes was discovered </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> is a rare clinical entity first described in 1965 and characterized by typical <z:mp ids='MP_0001212'>skin lesions</z:mp> (<z:hpo ids='HP_0000965'>livedo reticularis</z:hpo>) and cerebrovascular lesions occurring at early age </plain></SENT>
<SENT sid="2" pm="."><plain>Central <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:mp ids='MP_0006134'>artery occlusions</z:mp> have been reported twice in Sneddon-patients, but peripheral <z:chebi fb="46" ids="15035">retinal</z:chebi> capillary occlusions and neovascularization have not yet been reported </plain></SENT>
<SENT sid="3" pm="."><plain>The role of the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in this association is discussed </plain></SENT>
</text></document>